Sugammadex Vs Neostigmine in Reversing Neuromuscular Blocks in Outpatient ERCP. A Randomized, Double-Blinded Trial
NCT06136585
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Neuromuscular Blocks
Interventions
DRUG:
2 mg/kg sugammadex
DRUG:
0.07 mg/kg neostigmine
Sponsor
The Cleveland Clinic
Collaborators
[object Object]